Clinical Trial Update: Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 study by Novartis investigates additional effects of fluvastatin in patients with metabolic syndrome. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Lescol (fluvastatin)

Snippet

Sponsor: Novartis | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED